Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the company opened ...

The Company has added an Australian entity, Max Brazil, to hold the "Florália DSO Project" through the existing Canadian and Brazilian holding entities. As announced on January 9, 2025, Max Brazil ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Sources privy to the development said that the company is actively streamlining its operations to address various challenges ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

BloombergNEF says in a new report that global clean energy investment reached $2.1 trillion in 2024, more than doubling 2020 ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

A report on energy transition investments from BloombergNEF showed that global investment in clean energy technologies hit a ...

Shares in Venture Global are expected to make their debut on the New York Stock Exchange after the company raised $1.75 ...

Oilfield services provider Baker Hughes said on Thursday it has signed an agreement with Venture Global to support its ...

Taking yet another step in its preparations for its IPO, B2B marketplace unicorn OfBusiness has converted itself into a ...